Literature DB >> 11854439

Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population.

Eleni Aklillu1, Mikael Oscarson, Mats Hidestrand, Brith Leidvik, Charlotta Otter, Magnus Ingelman-Sundberg.   

Abstract

Cytochrome P450 1B1 (CYP1B1) is an extrahepatic enzyme of potential importance for the metabolism of estrogen and for metabolic activation of environmental carcinogens. We investigated an Ethiopian population for functional polymorphisms in the CYP1B1 gene using genomic DNA sequencing and detected three novel single nucleotide polymorphisms (SNPs). One of these (4360C-->G in exon 3) is present at a frequency of 7% and causes an Ala443Gly amino acid substitution. In addition, the four described previously missense mutations Arg48Gly, Ala119Ser, Leu432Val, and Asn453Ser were found with frequencies of 51, 50, 53, and 2%, respectively, yielding a total of 32 possible CYP1B1 haplotypes. Allele-specific PCR methods for haplotype analysis were developed and seven different CYP1B1 alleles were found: CYP1B1*1, *2, *3, *4, *5, *6, and *7 with frequencies of 8, 37, 39, 2, 0.7, 6, and 7%, respectively. The functional properties of different forms of CYP1B1, as well as of the Leu432Val + Asn453Ser and Leu432Val + Ala443Gly variants, were evaluated after heterologous expression of the corresponding cDNAs in Saccaromyces cerevisiae. The results revealed that CYP1B1.6 and CYP1B1.7, having the amino acid substitutions Arg48Gly, Ala119Ser, and Leu432Val in common, exhibited altered kinetics with significantly increased apparent K(m) and lowered V(max) values for both the 2- and 4-hydroxylation of 17 beta-estradiol, whereas the other constructs were indistinguishable from the CYP1B1.1 enzyme. The results emphasize the necessity of a complete haplotype analysis of enzyme variants for evaluation of functional consequences in vivo and for analyses of genetic polymorphisms in relation to, for example, cancer incidence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854439     DOI: 10.1124/mol.61.3.586

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  18 in total

Review 1.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

2.  Comparative docking studies of CYP1b1 and its PCG-associated mutant forms.

Authors:  Malkaram Sridhar Achary; Hampapathalu Adimurthy Nagarajam
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

3.  Association of polymorphisms and haplotypes in the cytochrome P450 1B1 gene with uterine leiomyoma: A case control study.

Authors:  Saeedeh Salimi; Maryam Khodamian; Mehrnaz Narooie-Nejad; Azam Hajizadeh; Kimia Fazeli; Lida Namazi; Minoo Yaghmaei
Journal:  Biomed Rep       Date:  2014-12-31

4.  ["Genes for mitochondria" in arterial hypertension and left ventricular hypertrophy].

Authors:  S V Buĭkin; M V Golubenko; V P Puzyrev
Journal:  Mol Biol (Mosk)       Date:  2010 Jan-Feb

5.  Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors.

Authors:  Page E Abrahamson; Shelley S Tworoger; Erin J Aiello; Leslie Bernstein; Cornelia M Ulrich; Frank D Gilliland; Frank Z Stanczyk; Richard Baumgartner; Kathy Baumgartner; Bess Sorensen; Rachel Ballard-Barbash; Anne McTiernan
Journal:  Breast Cancer Res Treat       Date:  2006-11-01       Impact factor: 4.872

6.  CYP1B1 polymorphisms and k-ras mutations in patients with pancreatic ductal adenocarcinoma.

Authors:  Marta Crous-Bou; Immaculata De Vivo; Miquel Porta; José A Pumarega; Tomàs López; Joan Alguacil; Eva Morales; Núria Malats; Juli Rifà; David J Hunter; Francisco X Real
Journal:  Dig Dis Sci       Date:  2008-03-18       Impact factor: 3.199

Review 7.  Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.

Authors:  Magnus Ingelman-Sundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-22       Impact factor: 3.000

8.  CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma.

Authors:  R Melki; E Colomb; N Lefort; A P Brézin; H-J Garchon
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

9.  Single nucleotide polymorphisms and haplotypes of the genes encoding the CYP1B1 in Korean women: no association with advanced endometriosis.

Authors:  Yeon Jean Cho; Sung Eun Hur; Ji Young Lee; In Ok Song; Hye-Sung Moon; Mi Kyoung Koong; Hye Won Chung
Journal:  J Assist Reprod Genet       Date:  2007-06-12       Impact factor: 3.412

10.  Role of CYP1B1, MYOC, OPTN, and OPTC genes in adult-onset primary open-angle glaucoma: predominance of CYP1B1 mutations in Indian patients.

Authors:  Arun Kumar; Manjunath G Basavaraj; Santosh K Gupta; Imteyaz Qamar; Abdullah Mahmood Ali; Vineeta Bajaj; T K Ramesh; D Ravi Prakash; Jyoti S Shetty; Syril K Dorairaj
Journal:  Mol Vis       Date:  2007-04-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.